Partnership website: https://www.aspire2050.eu/p4planet/about-p4planet
P4Planet is a Horizon Europe co-programmed partnership with an overall budget of €2.6 billion, €1.3 billion from Horizon Europe and €1.3 billion for the private partners. The partnerships private partners are represented by A.SPIRE, with brings together more than 150 members.
P4Planet, the successor to the Horizon 2020 SPIRE Partnership, will aim to achieve three general objectives:
At least 10 leading sectors of the European Process Industry will be engaged in the implementation of the partnership. These include cement, steel, ceramics, chemicals, engineering, minerals and ores, non-ferrous metals, water, refineries, and pulp or paper.
The partnership works on emerging technologies and on the scaling up of already developed technologies at higher technology readiness levels (TRLs) to deliver expected CO2 emission reductions by 2030 and achieve their full impact by 2050. Proactive and continuous engagement with EU countries, regions, civil society, other research and innovation partnerships and initiatives, and other relevant stakeholders is crucial.
Contact
Partners: A.SPIRE - info@aspire2050.eu
About A.SPIRE
A.SPIRE represents innovative process industries, 20% of the total European manufacturing sector in employment and turnover, and more than 180 industrial and research process stakeholders from more than 20 countries spread throughout Europe. A.SPIRE brings together cement, ceramics, chemicals, engineering, minerals and ores, non-ferrous metals, pulp and paper, refining, steel and water sectors, several being world-leading sectors operating from Europe.
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.